CLINICAL_TRIALS
trial_result
· 2025-04-01
Clinical Trial Update: Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction [Phase 2]
Summary
Phase 2 clinical trial evaluating GeranylGeranylAcetone for heart failure with preserved ejection fraction has completed. Sponsor/locations include Amsterdam UM…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amsterdam UMC, location VUmc | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: COMPLETED